Antioxydant < Antiparkinsonien < Antiphospholipide syndrome

Facettes :

List of bibliographic references indexed by Antiparkinsonien

Number of relevant bibliographic references: 255.
[20-40] [0 - 20][0 - 50][40-60]

Ident.	Authors (with country if any)	Title
004316 (2002)	Robert A. Hauser [États-Unis] ; Nicholas H. G. Holford [Nouvelle-Zélande]	Quantitative description of loss of clinical benefit following withdrawal of levodopa–carbidopa and bromocriptine in early Parkinson's disease
004346 (2002)	Christopher G. Goetz [États-Unis] ; Sue Leurgans [États-Unis] ; Rema Raman [États-Unis]	Placebo‐associated improvements in motor function: Comparison of subjective and objective sections of the UPDRS in early Parkinson's disease
004360 (2002)	Giulio Cicarelli [Italie] ; Maria Teresa Pellecchia [Italie] ; Giuseppe De Michele [Italie] ; Gilberto Pizzolato [Italie] ; Paolo Barone [Italie]	Paradoxical response to apomorphine in a case of atypical parkinsonism
004365 (2002)	Ruth Djaldetti [Israël] ; Rivkah Inzelberg [Israël] ; Nir Giladi [Israël] ; Amos D. Korczyn [Israël] ; Yehudit Peretz-Aharon [Israël] ; Martin J. Rabey [Israël] ; Yuval Herishano [Israël] ; Silvia Honigman [Israël] ; Sami Badarny [Israël] ; Eldad Melamed [Israël]	Oral solution of levodopa ethylester for treatment of response fluctuations in patients with advanced Parkinson's disease
004380 (2002)	Craig D. Mccoll [Australie] ; Katrina A. Reardon [Australie] ; Mark Shiff [Australie] ; Peter A. Kempster [Australie]	Motor response to levodopa and the evolution of motor fluctuations in the first decade of treatment of Parkinson's disease
004401 (2002)	Miriam Vélez [Pérou] ; Carlos Cosentino [Pérou] ; Luis Torres [Pérou]	Levodopa‐responsive rubral (Holmes') tremor
004402 (2002)	Gurutz Linazasoro [Espagne] ; Nadege Van Blercom [Espagne] ; Asier Lasa [Espagne] ; Bego A Indakoetxea [Espagne] ; Javier Ruiz [Espagne]	Levodopa‐induced ocular dyskinesias in Parkinson's disease
004404 (2002)	Jong-Min Kim [Corée du Sud] ; Ki Hyeong Lee [Corée du Sud] ; Yoon-La Choi [Corée du Sud] ; Gi Yeong Choe [Corée du Sud] ; Beom S. Jeon [Corée du Sud]	Levodopa‐induced dyskinesia in an autopsy‐proven case of progressive supranuclear palsy
004406 (2002)	Marie-Paule Muriel [France] ; Gaël Orieux [France] ; Etienne C. Hirsch [France]	Levodopa but not ropinirole induces an internalization of D1 dopamine receptors in parkinsonian rats
004427 (2002)	Valerie E. Kelly [États-Unis] ; Allie S. Hyngstrom [États-Unis] ; Melissa M. Rundle [États-Unis] ; Amy J. Bastian [États-Unis]	Interaction of levodopa and cues on voluntary reaching in Parkinson's disease
004428 (2002)	Luc J. P. Defebvre [France] ; Pierre Krystkowiak [France] ; Jean-Louis Blatt [France] ; Alain Duhamel [France] ; Jean-Louis Bourriez [France] ; Myriame Périna [France] ; Serge Blond [France] ; Jean-Daniel Guieu [France] ; Alain Destée [France]	Influence of pallidal stimulation and levodopa on gait and preparatory postural adjustments in Parkinson's disease
004468 (2002)	J. Carsten Möller [Allemagne] ; Karin Stiasny [Allemagne] ; Volker Hargutt [Allemagne] ; Werner Cassel [Allemagne] ; Heiko Tietze [Allemagne] ; J. Hermann Peter [Allemagne] ; H. Eter Krüger [Allemagne] ; Wolfgang H. Oertel [Allemagne]	Evaluation of sleep and driving performance in six patients with Parkinson's disease reporting sudden onset of sleep under dopaminergic medication: A pilot study
004474 (2002)	Alexander Fisher [Australie] ; James Croft-Baker [Australie] ; Michael Davis [Australie] ; Patrick Purcell [Australie] ; Allan J. Mclean [Australie]	Entacapone‐Induced Hepatotoxicity and Hepatic Dysfunction
004475 (2002)	Ashfaq A. Sharif [États-Unis]	Entacapone in restless legs syndrome
004484 (2002)	Julie A. Robichaud [États-Unis] ; Kerstin D. Pfann [États-Unis] ; Cynthia L. Comella [États-Unis] ; Daniel M. Corcos [États-Unis]	Effect of medication on EMG patterns in individuals with Parkinson's disease
004497 (2002)	Chin-Song Lu [Taïwan] ; Yah-Huei Wu Chou [Taïwan] ; Tzu-Chen Yen [Taïwan] ; Chon-Haw Tsai [Taïwan] ; Rou-Shayn Chen [Taïwan] ; Hsiu-Chen Chang [Taïwan]	Dopa‐responsive parkinsonism phenotype of spinocerebellar ataxia type 2
004499 (2002)	Oleh Hornykiewicz [Autriche]	Dopamine miracle: From brain homogenate to dopamine replacement
004502 (2002)	J. E. Rice [Australie] ; R. Antic [Australie] ; Philip D. Thompson [Australie]	Disordered respiration as a levodopa‐induced dyskinesia in Parkinson's disease
004535 (2002)	Azi H. Rajput [Canada] ; Mark E. Fenton [Canada] ; Sam Birdi [Canada] ; Rob Macaulay [Canada] ; David George [Canada] ; Bohdar Rozdilsky [Canada] ; Lee C. Ang [Canada] ; Ambikaipakan Senthilselvan [Canada] ; Oleh Hornykiewicz [Autriche]	Clinical–Pathological study of levodopa complications
004544 (2002)	Joanne E. Nash [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni]	Characterisation of striatal NMDA receptors involved in the generation of parkinsonian symptoms: Intrastriatal microinjection studies in the 6‐OHDA‐lesioned rat
004550 (2002)	Jakob Christensen [Danemark] ; Erik Dupont [Danemark] ; Karen Stergaard [Danemark]	Cabergoline plasma concentration is increased during concomitant treatment with itraconazole

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i -k "Antiparkinsonien" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i  \
                -Sk "Antiparkinsonien" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    PascalFr.i
   |clé=    Antiparkinsonien
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024